Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure supports the construction of complex piperazine-based compounds with potential antipsychotic, antidepressant, or cognitive-enhancing activity. Commonly employed in medicinal chemistry for scaffold modification and structure-activity relationship studies. Also utilized in the preparation of receptor ligands, especially for serotonin and dopamine receptors, due to the presence of the functionalized piperazine core. Suitable for solid-phase and solution-phase peptide-like synthesis in drug discovery programs.